Solid Tumor Cancer Clinical Trials

59 clinical trials for Solid Tumor Cancer across international registries, including 29 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• JL19001 Injection Alone or in Combination With Standard Therapy in Patients With Advanced Solid Tumors or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma — RECRUITING · PHASE1
• Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer — RECRUITING
• BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001) — RECRUITING · PHASE1
• Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial — RECRUITING · NA
• Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors — RECRUITING · PHASE1
• A First in Human Study of PLT012 in Participants With Solid Tumor Cancers — RECRUITING · PHASE1
• Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors — RECRUITING · PHASE2
• Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). — RECRUITING · PHASE1
• A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products — RECRUITING
• QLS5212 for Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001) — RECRUITING · PHASE1
• Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors — RECRUITING · PHASE1
• Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• A Clinical Study of Personalized Self-DC Vaccine Targeting Neoantigen in Treatment of Advanced Solid Tumor — RECRUITING · NA
• IN10018 in Combination With RNK08954 for the Treatment of KRASG12D Mutation-Positive Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors — RECRUITING
• Implementation of the Methylome in the Characterization of Solid Tumors — RECRUITING
• A Phase I Study of WTX212A Monotherapy or in Combination With Radiotherapy in Patients With Advanced Solid Tumors — RECRUITING · PHASE1
• A Single-arm Clinical Trial Using Patient-derived Tumor Tissue Fragment Models for Drug Sensitivity Testing to Guide Treatment in Previously Treated Cancers — RECRUITING · PHASE2
• Study of GV20-0251 in Participants With Solid Tumor Malignancies — RECRUITING · PHASE1
• A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors — RECRUITING · PHASE1
• A Study of a Distress Screening and Referral Program in People With Recently Diagnosed Cancer — RECRUITING · NA
• Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors — RECRUITING · PHASE1
• Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases — RECRUITING · NA
• Imatinib and Trametinib for KRAS-mutated Solid Tumor — RECRUITING · PHASE1
• Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor — RECRUITING · PHASE1
• AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• A Phase I Study of LXP1788 Injection with Advanced Solid Tumors. — RECRUITING · PHASE1
• A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Collection of Multimodal Data (Including Clinical Data, Imaging Data and Omics Data) in Oncology — RECRUITING
• Impact of Duffy-null Associated Neutropenia on Chemotherapy Dosing — NOT_YET_RECRUITING · PHASE1
• AI-Driven Tumor Response Evaluation for Solid Tumors — NOT_YET_RECRUITING
• Feasibility and Acceptability of the Remote Oncology Symptom Assessment Application — COMPLETED · NA
• Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) — ACTIVE_NOT_RECRUITING
• A Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With High Risk Cutaneous Squamous Cell Carcinoma — WITHDRAWN · PHASE1
• Imaging Study of [89Zr]DFO-YS5 for Cancer Detection — NOT_YET_RECRUITING · PHASE1
• Safety, Tolerability, and Preliminary Antitumor Activity of Non-Cationic Peptide-CD47 siRNA in Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• Imaging of Solid Tumors Using DLL3 SPECT — WITHDRAWN · PHASE1
• Bioequivalence Study of Trifluridine and Tipiracil Hydrochloride Tablets on Fasting and Fed in Humans — COMPLETED · NA
• Study of DF6215 in Patients With Advanced Solid Tumors — COMPLETED · PHASE1
• Pilot Study Evaluating Tumor Microenvironment Interaction in Solid Tumor Patients — WITHDRAWN · PHASE1
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903 — COMPLETED · PHASE1
• Safety and Efficacy of Combining a Vitamin B6-Limited Diet With Immunotherapy in Solid Tumor Patients: A Clinical Study Protocol — NOT_YET_RECRUITING · PHASE1
• A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors — NOT_YET_RECRUITING
• Safety and Efficacy of an Arginine-Restricted Diet in Patients With Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Dose-escalation, Dose-finding, and Expansion Study of XL495 in Participants With Locally Advanced or Metastatic Solid Tumors — TERMINATED · PHASE1
• MNPR-101-PCTA-177Lu Expanded Access Program (EAP) for Patients With Solid Tumor Cancer — OTHER
• A Phase I, First-in-Human Study of GB268 (PD-1/CTLA-4/VEGF Trispecific Antibody) in Advanced Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Study of Exercise Therapy in People With Solid Tumor Cancer — WITHDRAWN · PHASE1
• Irinotecan Liposomes Combined with Temozolomide and Vincristine in the Treatment of Pediatric Patients with Solid Tumors — NOT_YET_RECRUITING · PHASE1
• A Multi-cohort Study of Efbemalenograstim Alfa Injection for Preventing ANC Reduction in Solid Tumor Patients Post Immune-chemotherapy. — NOT_YET_RECRUITING · NA

Refine this search